Pentwater Capital Management LP
CIK 1425851 · last filed 2026-05-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
CAR price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 216
NAPLES, FL 34102
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CAR | 10%+ Owner | 3,485,000 | $103.34 | $360.14M | -$6.97B | 21 | 2026-05-12 |
| Tobira Therapeutics, Inc. (TBRA) Delisted | 10%+ Owner | 3,753,200 | — | — | $72.30M | 7 | 2016-11-02 |
| STEWART ENTERPRISES INC (STEI) Delisted | 10%+ Owner | 7,500,000 | — | — | -$22.18M | 7 | 2013-05-24 |
| DTG | 10%+ Owner | 2,793,322 | $14.76 | $41.23M | $6.76M | 7 | 2012-07-17 |
Recent Filings · Page 3 of 5
42 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-24 | CAR | Mixed | +510,200 | $51.18M | EDGAR |
| 2016-11-02 | Tobira Therapeutics, Inc. (TBRA) Delisted | Buy (P) | +15,000 | $627.6K | EDGAR |
| 2016-10-19 | Tobira Therapeutics, Inc. (TBRA) Delisted | Buy (P) | +40,000 | $1.60M | EDGAR |
| 2016-10-06 | Tobira Therapeutics, Inc. (TBRA) Delisted | Buy (P) | +4,481 | $178.5K | EDGAR |
| 2016-09-30 | Tobira Therapeutics, Inc. (TBRA) Delisted | Buy (P) | +15,519 | $612.8K | EDGAR |
| 2016-09-28 | Tobira Therapeutics, Inc. (TBRA) Delisted | Buy (P) | +50,000 | $1.95M | EDGAR |
| 2016-09-23 | Tobira Therapeutics, Inc. (TBRA) Delisted | Buy (P) | +100,000 | $3.92M | EDGAR |
| 2016-09-22 | Tobira Therapeutics, Inc. (TBRA) Delisted | Buy (P) | +1,624,200 | $63.41M | EDGAR |
| 2013-05-24 | STEWART ENTERPRISES INC (STEI) Delisted | Sell (S) | −1,663,488 | -$15.84M | EDGAR |
| 2013-05-21 | STEWART ENTERPRISES INC (STEI) Delisted | Sell (S) | −186,512 | -$1.73M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.